I am planning to generate cardiac spheroids using induced pluripotent stem cells (iPSCs). However, I need some guidance in selecting the most suitable forms for my experiment.

1. CHIR-99021 Variants: I noticed that CHIR-99021 is available in multiple modified forms, including:

  • Laduviglusib monohydrochloride
  • Laduviglusib trihydrochloride
  • Laduviglusib dihydrochloride
  • Laduviglusib (GMP)
  • Laduviglusib (Standard)

Which form would be most appropriate for this study, considering I am following a protocol for cardiac spheroid generation?

2. BMP-4 (Cat. No.: HY-P10710): Can this catalogue be used for mesoderm induction in human iPSC differentiation?

3. Activin A Protein, Human/Mouse/Rat (HEK293) (Cat. No.: HY-P70311):

  • The study focuses on human iPSCs. Is there any significant difference between the Activin A molecule of human, mouse, and rat that could impact my differentiation protocol?
  • Would this specific catalog number be suitable for my application?

4. Wnt-C59 (Cat. No.: HY-15659):

  • Is this an oral formulation, or can it be directly used in culture media for my differentiation experiments?

More Lucian Miles's questions See All
Similar questions and discussions